|
    BTAL U.S.: NYSE Arca

    AGFiQ U.S. Market Neutral Anti-Beta Fund

    BTALUS
    Closed
    Back To Top
    Last Updated: May 7, 2021 3:59 p.m. EDT Delayed quote

    $ 16.64

    -0.09 -0.54%
    Previous Close
    $16.73
    Advanced Charting
    • $
    • %
    • Vol
    Volume: 44.27K 65 Day Avg: 94.41K
    47% vs Avg
    16.63 Day Range 16.85
    16.46 52 Week Range 26.08

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    BTAL Overview

    Lipper Leader

    YTD Lipper Ranking:Quintile 5 (93rd percentile)
    • 2 Total Returns
    • 1 Consistent Return
    • 2 Preservation
    • 4 Tax Efficiency
    • 5 Expense

    Lipper Leaders Key

    • Highest
    • 5
    • 4
    • 3
    • 2
    • 1
    • Lowest

    Recent News

    • eLesor
    • Dow Jones
    Read full story

    Here’s how to play the trade war with ETFs

    Read full story

    These ETFs have your back when markets get rough

    Are ‘defensive equity funds’ the right play?

    • Other News
    • Press Releases

    Worried About Tax Hike and Surging Yields? 5 ETFs to Bet On

    on Zacks.com

    Worst Market Drop in About Two Weeks: ETF Strategies to Win

    on Zacks.com

    5 ETF Buying Zones on Market Gyrations

    on Zacks.com

    5 Big ETF Winners Amid Worst Market Crash Since March

    on Zacks.com

    5 ETFs for Protection From Market Crash

    on Zacks.com

    Top ETF Stories of First Quarter

    on Zacks.com

    5 ETFs That Outperformed in Q1

    on Zacks.com

    Long-Short ETF (BTAL) Hits New 52-Week High

    on Zacks.com

    Don't Fear the Bear: 5 ETFs to Bet on

    on Zacks.com

    Long/Short ETFs to Fight Market Crash

    on Zacks.com

    ETF Strategies to Play the Rising Virus-Induced Volatility

    on Zacks.com

    Go Defensive With These ETFs as Stock Rout May Worsen

    on Zacks.com

    Wall Street Crashes: 5 Defensive ETFs to Your Rescue

    on Zacks.com

    Top 10 Holdings

    Company Symbol Total Net Assets
    Vir Biotechnology Inc. VIR 1.12%
    Novavax Inc. NVAX 1.11%
    Moderna Inc. MRNA 0.71%
    MongoDB Inc. MDB 0.69%
    Valmont Industries Inc. VMI 0.68%
    Eli Lilly & Co. LLY 0.67%
    Bank OZK OZK 0.67%
    Fortinet Inc. FTNT 0.67%
    Interactive Brokers Group Inc. IBKR 0.67%
    CrowdStrike Holdings Inc. Cl A CRWD 0.67%
    View More Holdings As of 02/28/2021

    ETF Details

    Category Equity Mkt Neutral
    Portfolio Style Equity Mkt Neutral
    Fund Status Open
    Fund Inception September 12, 2011
    Managers
    DeRoche
    Lee
    Belko

    Investment Policy

    The Fund seeks performance results that correspond to the price and yield performance of the Dow Jones U.S. Thematic Market Neutral Anti-Beta Index. The Funds invest at least 80% of its net assets in common stocks that are in the Target Anti-Beta Index.

    Distribution History

    Date Income Distribution
    YTD -
    2020 -
    2019 $0.20
    2018 $0.09
    2017 -
    2016 -
    2015 -
    2014 -
    2013 -
    2012 -
    2011 $0.02